Three Seasons Wealth »

Arrowhead Pharmaceuticals shares owned by Three Seasons Wealth

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Three Seasons Wealth from 13F filings

Historical chart of Three Seasons Wealth investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Three Seasons Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Three Seasons Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $584k 9.3k 62.70

More positions owned by Three Seasons Wealth

Proshares Tr Short S&p 500 Ne (SH)
Spdr Gold Tr Gold Shs (GLD)
Spdr Series Trust State Street Spd (BIL)
Goldman Sachs Etf Tr Ultra Short Bond (GSST)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Amazon (AMZN)
Innovator Etfs Trust Us Eqty Pwr Buf (PNOV)
Ishares Tr U.s. Bas Mtl Etf (IYM)
Lam Research Corp Com New (LRCX)
Ishares Tr Us Telecom Etf (IYZ)
Proshares Tr Ultrashrt S&p500 (SDS)
Ishares Tr Us Industrials (IYJ)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr U.s. Energy Etf (IYE)
NVIDIA Corporation (NVDA)

View all positions for Three Seasons Wealth

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Vanguard Portfolio Management
FMR
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Fred Alger Management
Invesco
Slate Path Capital
Vestal Point Capital
Arrowstreet Capital, Limited Partnership
Baker Bros. Advisors
Driehaus Capital Management

View all funds holding Arrowhead Pharmaceuticals